General medical practice activities
EUROPEAN ONCOLOGY LAB AS
Revenue 2024
NOK 33,000
Operating profit
NOK −59,000
Equity
NOK −69,000
Incorporated
2018
Share capital
NOK 30,000
Key figures · 2024
Current ratio
2.28
Equity ratio
-123.3%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -176.6% | |
| Net margin (%%) | -180.2% | |
| Return on assets (%%) | -105.1% | |
| Likviditet | ||
| Current ratio | 2.28 | |
| Working capital | 31k | |
| Soliditet | ||
| Equity ratio (%%) | -123.3% | |
| Debt-to-equity ratio | -1.81 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.